1 Am.J. Hum. Genet. 56: , 1995 BACKGROUND STATEMENT Genetic Testing and Insurance The Ad Hoc Committee on Genetic Testing/insurance Issues Background The rapid expansion of genetic technology raises complex questions about the relationships among practitioners, patients, and insurers. In 1991, The American Society of Human Genetics (ASHG) appointed an Ad Hoc Committee on Insurance Issues in Genetic Testing to explore these issues. The purpose of this paper is to assist members of the ASHG and others who provide genetic services to better understand the issues so that they can consider the policy options that must be resolved. We hope this will prepare the ASHG membership to anticipate problems and to foster further discussion within the society, which will lead to an ASHG position paper on the issues. Many other groups are considering these issues and developing background papers and policy recommendations (Office of Technology Assessment, U.S. Congress 1988; Mitchell et al. 1991; Moseley et al. 1991; Pokorski 1992; NIH-DOE 1993; Ostrer et al. 1993), and a number of scholars are turning their attention to this area (Andrews 1991; Holtzman and Rothstein 1992; Kass 1992; Murray 1992). For those interested in a brief background on the basic features of the American insurance system, we recommend the NIH-DOE (1993) report and the review by Ostrer et al. (1993). The Basic Premise of Insurance Insurance products are developed to provide financial protection against unanticipated loss. While everyone will die and most will at some time become seriously ill, we generally do not expect to die early, and we all believe it will be someone else who will be disabled or become ill. Insurance is sold to replace income or to pay for health care on the chance that one of these unanticipated events occurs. It is a means of mitigating loss. Standard premiums are calculated on the expected outcome for large numbers of individuals with similar risks and are expected to spread the cost of the loss among a group. Prior to issuing a pol- Address for correspondence: Dr. Maimon M. Cohen, Department of Obstetrics and Gynecology, Division of Human Genetics, University of Maryland, Baltimore, MD Address for reprints: Elaine Strass, Executive Office of ASHG, 9650 Rockville Pike, Bethesda, MD by The American Society of Human Genetics. All rights reserved /95/ $02.00 icy, however, insurers must determine the risk that an individual client presents and must adjust their premium to acknowledge that risk. The process is called underwriting. The commercial insurance industry in the United States has traditionally served the important functions of providing citizens with the opportunity to spread their risks among a large community while allowing legitimate businesses to earn a profit. When insurance policies rely more on risks of only a few individuals or small groups, this social function is lost. The ability to identify and exclude high-risk individuals can result in the paradoxical situation of insurance being most easily available to those who need it the least. With regard to health insurance, this problem is accentuated when the cost of insurance is borne primarily by employers and is particularly true in small businesses whose profits and even survival may be threatened by serious illness in a few employees. Insofar as this is a social problem, it is not solely the responsibility of the insurance industry to ensure access to health care for all (Kass 1992; Murray 1992). This tension between the legitimate business goals of the private insurance industry and the social need for universal access to health care has accelerated public pressure for a national policy that will reconcile the two goals. The Problem of Defining Genetic Conditions and Tests Definitions can become important when insurance policies and laws distinguish genetic conditions and genetic tests from other medical conditions and tests. While some conditions (e.g., Tay-Sachs disease) have a virtually purely genetic basis, most genetic disorders involve an interaction between a genetic predisposition and environmental factors. Even single-gene disorders (e.g., sickle-cell disease and cystic fibrosis) have variable expression depending in part on such environmental factors as oxygen tension in the former and nutritional factors in the latter. Similarly, some tests, such as those involving mutation analysis, might seem to be clearly genetic tests, but many others, used to test for genetic disorders, measure gene products or further-removed effects. The latter include many tests that could be considered genetic tests, such as Guthrie spots, which test for elevated levels of phenylalanine, or any X-ray used to diagnose or rule out achondroplasia. The point of these observations is that there is no clear boundary between genetic and nongenetic conditions and tests. 327
2 328 Implication for Different Types of Insurance Medical assessment, including the use of genetic information, is often used in underwriting of health, life, and disability insurance, but the nature of the assessment and the principles of underwriting vary for each type of insurance product. In social policy terms the need for basic health care and disability income replacement is quite different from the need for life insurance. These differences should be considered when one is discussing the implications of genetic testing of insurance applicants. Am.J. Hum. Genet. 56: , 1995 Health Insurance The practices of insurers regarding reimbursement for genetic testing and services, including counseling and treatment, are usually explicit in policies when they are issued. In general, reimbursement for testing is provided when the test is "medically indicated," usually requiring that the patient be symptomatic. Genetic testing might also be considered to be indicated if there is a positive family history for the condition in question. This standard will become increasingly problematic with the development of new tests that arguably should be offered to the public or a large subpopulation. Present examples include phenylketonuria testing of newborns, Tay-Sachs testing of Jewish individuals of Ashkenazic descent, and sickle-cell testing of African Americans. Reimbursement practices are affected by standard medical practices. A recommendation by a professional society that a test is indicated under specified circumstances will influence insurance policies on reimbursement. In general, insurance companies look to health professionals for guidance as to whether a test is medically indicated. In addition to reimbursement for laboratory tests, clinicians and patients are also concerned about reimbursement for pretest and posttest counseling. It is generally acknowledged that reimbursement for counseling is inadequate. Widely accepted guidelines for genetic testing emphasize the necessity of education and counseling so that people can make informed choices on whether to be tested, as well as informed choices regarding reproductive (and other) decisions, particularly if a test result is abnormal (Committee on Assessing Genetic Risks 1994). A more serious question is whether insurers would pay for medical services or deny coverage to patients whose genetic disease could be classified as a preexisting condition. Considerable ambiguity exists in characterizing an individual who has been found to have the allele for Huntington disease. Some would argue that he or she only has the predisposition to develop the condition at a later time. An insurer, however, might argue that the condition is present, albeit in latent form, as soon as the individual acquired-or knew that he or she had acquired-the abnormal gene. Insurance company policies on these matters will obviously affect individuals' willingness to be tested. Adverse policies could discourage individuals from seeking testing and thereby could deprive them of the opportunity of either obtaining timely treatment or making reproductive choices that might, in the long run, both improve health and reduce the cost of health care for the insurer and others. Such practices could also discourage patients from volunteering for research studies involving genetic testing. Life Insurance Approximately 70% of adults have some form of life insurance. Some of these are group policies with little or no medical underwriting, but approximately three-quarters are purchased individually. The amount of information sought depends in part on the amount of coverage for which an individual applies. Approximately 97% of all applications for ordinary life insurance are accepted, while 3% are rejected. Of those accepted, <5% are required to pay higher than standard premiums (Morton 1984). Disability Insurance Disability income insurance pays the policyholder a portion of his or her income in the event of illness or injury. Such policies vary in several regards, including how long before payments begin, how long payments continue, the extent to which the disability must incapacitate the individual, and whether the individual must be able to work at all or simply not be able to work at his or her usual occupation. Types of disability insurance include Social Security Disability Insurance, group policies, life insurance riders, workers compensation for job-related disability, and individual policies. Since there are many more conditions that disable rather than kill, and since the amount of payout is often much larger, the standards for writing disability insurance are much stricter than those for life or health insurance. Applications are therefore more likely to generate deeper inquiries into medical background and, possibly, to elicit more testing. Ethical and Policy Questions Risk Classification Distinguishing and classifying individuals at different risks is at the heart of commercial insurance as it is practiced today, particularly when individual and small group policies are involved. Insurers do not believe that genetic conditions- or genetic tests that predict illness, death, or disability should be excluded from this traditional practice. Differentiation of applicants on the basis of health risks is legal and should be distinguished from discrimination, which is illegal if based on race, gender, or sexual orientation. The extent of such legal discrimination at present is not clear, nor can its future course be predicted with any clar-
3 ASHG Background Statement ity. There have been reports of denial of coverage on the basis of genetic information (Billings et al. 1992), though some have questioned the validity of many of these claims (Lowden 1992). At present it appears that insurance companies do not require genetic tests, particularly molecular tests, in underwriting. This is partly because of both the rarity of most genetic disorders and the high cost of such tests, as well as unfamiliarity with their validity and usefulness in the insurance setting. However, "multiplexing" of tests could result in marked reductions in cost, so that genetic testing could become as commonplace as multiphasic chemistry tests or multiple tests on a urine sample. Although insurers may not now require genetic testing, they nevertheless do make decisions based on genetic information, including family history or prior diagnostic tests performed in the course of delivery of medical care to the applicant and his or her family. Information may be obtained from an application form, a medical record, or other sources, such as the MIB (1993). This is a nonprofit cooperative agency formed by member insurance companies to combat fraud. It consists of a large database of insurance applicants identified by name, birth date, and state. A series of codes describes broad classes of medical impairments with qualifying dates and sources of information included in each file. Governed by a strict code of regulations, the MIB provides a service to underwriters and is used only during the underwriting of new applications. Member companies can only access the data during the application process and only with the consent of the applicant. Insurers can access the database only to confirm that they have reviewed the same relevant information on the medical history of the applicant that has been collected by their competitors. The information cannot be used to directly rate or deny insurance to an applicant; it can be used only as a guide to further investigation by the requesting company. MIB information is purged after 7 years. Although many diseases are clearly genetic or have a significant genetic component, MIB codes include only a few genetic diseases (e.g., cystic fibrosis and hemophilia), while most would be coded under rather obscure general categories. Huntington disease, for example, is coded as "disorder of the central nervous system for which there is no specific code." The same code is used for amyotrophic lateral sclerosis, encephalitis, and Bell palsy. There are no listings for heterozygotes for recessively inherited conditions. The availability of insurance will also be affected by the definition of "preexisting conditions," since health insurance and disability insurance policies commonly exclude coverage for such conditions. It could be argued that a person found to be carrying a gene, even though not symptomatic until late in life, has had the "condition" since birth. A different definition of "preexisting," closer to the common understanding of the term, would center on previously diagnosed or treated conditions. 329 The possibility that information concerning an individual's genetic status could be used to determine "insurability" or premium rates is likely to alter standards of informed consent for genetic testing. The very high value placed on autonomy in medical decision making requires that individuals be informed of risks reasonably to be expected before they decide whether to undergo a medical procedure. Denial of health insurance, in particular, can be a catastrophic event. If there is a reasonable risk of such denial, those responsible for obtaining consent to testing ought to disclose it. Concealment of medical information (genetic or otherwise) by health-care providers is an important issue. If an insurer is considering a claim and finds that the attending physician has not disclosed all the medical information in the report submitted with the application, the claim may be denied. In authorizing the attending physician to report to the insurer, the applicant signs a waiver that usually says that all "pertinent information" should be sent. If the insured becomes ill or dies and an omission of information is uncovered, the insurer may rescind the policy and return the premiums but not honor the claim. The attending physician may then be at risk of a litigation initiated by the insured (whom the physician was originally trying to protect). Adverse Selection Adverse selection occurs when individuals have more information about their risk of illness than do insurance companies -and base their insurance-purchasing decisions on such information. The imbalance allows these individuals at higher risk to buy more insurance yet pay no more than those at lower risk. This may jeopardize the economic well-being of the insurance company or require companies to raise all premiums, as protection against adverse selection. The latter approach imposes costs on others who are not at higher risk. In addition to the deception involved, this seems to conflict with the current practice in our society -that the cost of insurance should be higher for those at higher risk. Adverse selection poses a greater problem for life and disability insurance than for health insurance, since the latter is less discretionary. Health insurance is typically obtained through groups, whereas life and disability insurance are more commonly obtained through an individual application. In addition, few individuals can afford to forgo health insurance and will therefore generally pay higher premiums. Some would argue that the basic premise of charging more for those at higher risks is ethically flawed. According to this view, genetic conditions are never the individual's "fault" and should therefore never be the basis for insurance discrimination. Insurers, on the other hand, will point out that a brain abscess or subacute bacterial endocarditis is also not an individual's fault but nevertheless is
4 330 a condition that increases an applicant's risk and might warrant a premium rating. The basic principle of pricing commercial insurance states that risks are spread among a group of equals. Persons at higher risk are placed in a higher (more costly) pool. Critics of the health insurance industry emphasize the inequality of the present system, which allows companies to practice "adverse rejection" i.e., to discontinue coverage when a client, who has been faithfully paying premiums, is found to have a serious condition. It is to be hoped that health care - reform legislation will eliminate this inequity. Genetic counselors must be cautious about the problem of adverse selection. A vigorous position of patient advocacy might lead a practitioner to tolerate or even advise a patient on how to maximize the benefits of genetic testing without risk of losing insurance or paying higher premiums. Others would oppose such a position, not only because of the deception involved if important information is withheld from insurers, but because they advocate cooperation between insurers and providers as the best way to achieve fair and reasonable policies in the long run. Confidentiality The central role of confidentiality in health care has been recognized since Hippocrates and has been reinforced repeatedly in contemporary writings and in the law. Patients will not be able to maximize the benefits of health care unless they feel secure in disclosing potentially embarrassing and stigmatizing information about themselves. Such trust is essential if the doctor is to obtain the information needed to provide competent care, and it is generally in society's interest for patients to seek medical help for health problems, whether they are infectious or genetic conditions that may present risks to others or are disabilities that interfere with leading full and productive lives. Like all principles, respect for confidentiality must have exceptions. Reporting of infectious diseases to state health departments and reporting of child abuse to appropriate agencies are such examples that are widely accepted, justified by the risk of harm that is preventable through state action. Some jurisdictions have held psychotherapists liable for not warning an identifiable victim of a patient's violent plans (Tarasoff v. Regents of the University of California 1976). These debates involve complex questions of whether a geneticist has a right or a duty to disclose genetic information to a relative without the consent of the patient. Disclosure of stigmatizing information in the absence of consent may occur during the claims process when an insurance company exchanges information with an employer, particularly in the case of small companies. Similarly, during underwriting, physicians commonly release an entire medical record to an insurer, thereby disclosing genetic information even though it was not specifically requested. Am.J. Hum. Genet. 56: , 1995 Legal Issues For 5 decades the regulation of insurance practices has been handled largely by state, not federal, law. Some states recently have enacted legislation that prohibits discrimination based on genetic conditions. The state laws vary, however, in whether they apply to all genetic conditions or only to certain enumerated ones. The Employee Retirement Income Security Act (ER- ISA), a federal law that regulates pension and benefit plans, does have significant impact on access to insurance. Section 514 of ERISA preempts state insurance laws from regulating self-insured health-benefit plans (Metropolitan Life Insurance Company v. Massachusetts 1985). This includes mandated benefits, antidiscrimination, high-risk pools, and other provisions. In McGann v. H & H Music Co. (1991), the employer had purchased a commercial group health insurance policy that provided for lifetime medical benefits of $1 million for all employees. Soon after Mr. McGann submitted his first claims for reimbursement under the policy, for treatment of AIDS, the employer canceled the policy, became self-insured, hired the same commercial insurer to serve as the claims administrator for the new plan, and reduced the maximum lifetime coverage for AIDS to $5,000 while retaining the $1 million limit for all other medical conditions. In a controversial decision, the U.S. Court of Appeals for the Fifth Circuit held that the employer was within its rights to amend the plan at any time and therefore did not violate the antidiscrimination provision of ERISA. The Americans with Disabilities Act (ADA) prohibits employment discrimination on the basis of disability. It applies to private-sector employers with >15 employees. The ADA does not prohibit an employer or an insurance company from underwriting risks, classifying risks, or administering the risks of a bona fide plan. The statute permits an employer not subject to state insurance laws (i.e., a self-insured employer) to establish and administer the terms of a bona fide benefit plan. Thus, especially as to selfinsured employers, differences in coverage or benefits for genetic conditions are lawful. The reach of the ADA will be decided over the years, in appellate courts, and therefore it is not clear to what extent it might regulate the use of genetic information by employers or insurers. Summary The rapid expansion of opportunities for genetic testing has been accompanied by complex questions about the appropriate relationships between providers, patients, and insurers. Some of these questions involve large public-policy decisions, such as whether the government should guarantee access to health care for all citizens. Universal access to health care, without regard to past, present, or future risk of disease, could eliminate risk-oriented un-
5 ASHG Background Statement 331 derwriting in health-care coverage. A positive response to that question will ameliorate other problems. Until universal access is reality, genetic testing and genetic diagnosis will raise important issues for the practicing geneticist. How much does a client need to know about insurance implications before consenting to a genetic test? Should patients be counseled to purchase insurance before being tested? Should genetic information be excluded from medical records before their release to insurance companies for routine reimbursements or underwriting? What are the ethical and legal responsibilities of the geneticist? Acknowledgments This document was drafted by the ASHG Ad Hoc Committee on Insurance Issues in Genetic Testing. Committee members are L. Andrews, American Bar Association, Chicago; B. Bowles Biesecker, Department of Molecular and Medical Genetics, University of Michigan, Ann Arbor; N. Fost, Department of Pediatrics and Medical Ethics, University of Wisconsin, Madison; L. G. Jackson, Department of Medicine, Division of Medical Genetics, Thomas Jefferson University, Philadelphia; N. Kass, Johns Hopkins University, Baltimore; J. A. Lowden, Crown Life Insurance Company, Regina, Saskatchewan; T. H. Murray, Center for Biomedical Ethics, Case Western Reserve University, Cleveland; J. Payne, Health Insurance Association of America, Washington, D.C.; P. R. Reilly, Shriver Center, Waltham, MA; and M. A. Rothstein, University of Houston Law Center, Houston. References Andrews LB (1991) Legal aspects of genetic information. Yale J Biol Med 64:29-40 Billings PR, Kohn MA, de Cuevas M, Beckwith J, Alper JS, Natowicz MR (1992) Discrimination as a consequence of genetic testing. Am J Hum Genet 50: Committee on Assessing Genetic Risks (1994) Assessing genetic risks. National Academy Press, Washington, DC Holtzman NA, Rothstein MA (1992) Eugenics and genetic discrimination. Am J Hum Genet 50: Kass NE (1992) Insurance for the insurers: the use of genetic tests. Hastings Cent Rep 22:6-11 Lowden JA (1992) Genetic discrimination and insurance underwriting. Am J Hum Genet 51: McGann v H & H Music Co, 946 F2d 401 (5th Cir 1991), cert denied, 113S Ct 481 (1992) Medical Information Bureau (MIB) (1993) Handbook and directory. Medical Information Bureau, Westwood, MA Metropolitan Life Insurance Company v Massachusetts, 471 US 724 (1985) Mitchell JA, Bates RD, Gunmere J, Pearson PH, Masterman JV, Rollard M (1991) Report of the ACLI-HIAA task force on genetic testing. American Council of Life Insurance, Washington, DC Morton GA (1984) Principles in life and health insurance. Life Office Management Association, Washington, DC Moseley RE, Crandall LA, Dewar MA, Nye D, Ostrer H (1991) Ethical implications of a complete human gene map for insurance. Business Prof EthicsJ 10:69-82 Murray TH (1992) Genetics and the moral mission of health insurance. Hastings Cent Rep 22:12-17 NIH-DOE Working Group on Ethical, Legal and Social Implications of Human Genome Research (NIH-DOE) (1993) Genetic information and health insurance: report of the Task Force on Genetic Information and Insurance. NIH publication National Institutes of Health, Bethesda Office of Technology Assessment, US Congress (1988) Medical testing and health insurance. OTA-H-384. US Government Printing Office, Washington DC Ostrer H. Allen W, Crandall LA, Moseley RE, Dewar MA, Nye D, McCrary SV (1993) Insurance and genetic testing: where are we now? Am J Hum Genet 52: Pokorski R (1992) Use of genetic information by private insurers: genetic advances: the perspective of an insurance medical director. J Ins Med 24:60-68 Tarasoff v Regents of the University of California (17 Cal 3d 425, 131 Cal Rptr 14, 551 P2d 334 (1976)
INSURANCE Insurance is a very important issue for people living with HIV. It is vital to your longterm stability and care that you attempt to maintain coverage that you receive through employment or other
65 Chapter 7 Insurance Introduction 7.1 The subject of genetic screening in relation to insurance is not new. In 1935 R A Fisher addressed the International Congress of Life Assurance Medicine on the topic,
Sarasota Personal Medicine 1250 S. Tamiami Trail, Suite 202 Sarasota, FL 34239 Phone 941.954.9990 Fax 941.954.9995 NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY
D. A copy of the certification form shall be maintained by the insurer and by the producing agent or broker in the policyholder's record for a period of five years from the date of issuance of the insurance
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY Adult Patient or Parent, for Minor Patient INSTITUTE: National Cancer Institute PRINCIPAL INVESTIGATOR: Raffit Hassan, M.D. STUDY TITLE: Tissue Procurement
Insurance Discrimination Michael Bachhuber, Attorney Wisconsin Coalition for Advocacy Fair or unfair discrimination Introduction Insurance discrimination is a bit different conceptually from other forms
JULY 11, 2007 VOLUME 3, NUMBER 5 Employers nationwide need to understand what is happening in Massachusetts. THE MASSACHUSETTS HEALTH CARE REFORM ACT: WHAT MUST EMPLOYERS DO? by Katherine J. Utz* email@example.com
HIPAA PRIVACY NOTICE THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN OBTAIN ACCESS TO THIS INFORMATION. INTRODUCTION PLEASE REVIEW IT CAREFULLY Moriarty
Massachusetts Institute of Technology Summary Plan Description for the Massachusetts Institute of Technology Long-Term Disability Plan July 1, 2009 Table of Contents Introduction 3 For Assistance or More
NOTICE OF PRIVACY PRACTICES The University of North Carolina at Chapel Hill UNC-CH School of Nursing Faculty Practice Carolina Nursing Associates THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU
NAPD Formal Ethics Opinion 14-1 Social workers and other healthcare professionals may not report child or elder abuse without the express contemporaneous permission of the lawyer for whom they are doing
Article 68. Health Insurance Portability and Accountability. 58-68-1 through 58-68-20: Repealed by Session Laws 1997-259, s. 1(a). Part A. Group Market Reforms. Subpart 1. Portability, Access, and Renewability
NOTICE OF PRIVACY PRACTICES FOR OUR PATIENTS POTOMAC PHYSICIAN ASSOCIATES, P.C. THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED OR DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION.
Connecticut Carpenters Health Fund Privacy Notice THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
North Carolina Statutes Health Insurance Portability and Accountability PART A. GROUP MARKET REFORMS SUBPART 1. PORTABILITY, ACCESS, AND RENEWABILITY REQUIREMENTS 58-68-25. Definitions; excepted benefits;
Member Rights, Complaints and Appeals/Grievances 5.0 5.1 Referring Members for Assistance The Member Services Department has representatives to assist with calls for: General verification of member eligibility
CHAPTER 13 Insurance 291 292 CHAPTER 13 Contents 13.1 HIV testing and life insurance................................. 294 13.2 The need for insurance.......................................... 295 13.2.1
Staker Parson Short Term Disability Income Protection Plan Effective Date: 01/01/2006 Contact Information Plan Administrator: Address and Telephone #: Claims Administrator: Address and Telephone #: Staker
Concordat and Moratorium on Genetics and Insurance 2014 Preface The Concordat and Moratorium on Genetics and Insurance has been updated to reflect the agreement s extension until 2019. The interim review
Wyoming School Boards Association Insurance Trust ( The Plan ) HEALTH CARE PLAN PRIVACY NOTICE THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS
Claim Packet Instructions Your Disability Benefit Claim This packet contains the forms necessary to apply for disability benefits. It also addresses common questions about Disability claims. Please save
NOTICE OF PRIVACY PRACTICES for Sony Pictures Entertainment Inc. [Para recibir esta notificación en español por favor llamar al número proviso en este documento.] This notice describes how medical information
VALPARAISO UNIVERSITY NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
Health Reform and the AAP: What the New Law Means for Children and Pediatricians Throughout the health reform process, the American Academy of Pediatrics has focused on three fundamental priorities for
American Heart Association Principles on Health Care Reform The American Heart Association has a longstanding commitment to approaching health care reform from the patient s perspective. This focus including
Predictivity, Genetic Testing and Insurance: North American Perspective Strasbourg, December 2007 Yann Joly, L.L.B, L.L.M. Projet génétique et société, Centre de recherche en droit public, Université de
STUDENT PROFESSIONALISM CMA Code of Ethics (Updated 2004 reviewed March 2012) This Code has been prepared by the Canadian Medical Association as an ethical guide for Canadian physicians, including residents,
SUN LIFE ASSURANCE COMPANY OF CANADA Policyholder: Nevada Public Employee Voluntary Life Plan Policy Number: 08703-001 Policy Effective Date: March 1, 2008 Policy Anniversary: March 1, 2009 Policy Amendment
ADULT REGISTRATION FORM Last Name First Name Middle Initial Date of Birth Age Identified Gender Street Address City State Zip Code Home Phone Cell Phone FINANCIALLY RESPONSIBLE PARTY (If different from
Chapter 3 Underwriting Practices An underwriter s objective is to know as much cants. A majority of BC/BS plans (20 of 25) about the applicant s health status as the applicant. represented by an underwriter
NOTICE OF PRIVACY PRACTICES This notice describes how medical information about you may be used and disclosed and how you can access this information. Please read it carefully. If you have any questions,
NOTICE OF PRIVACY PRACTICES COMPLETE EYE CARE THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED OR DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
APOSTOLIC CHRISTIAN HOME OF EUREKA NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW
Health Insurance Portability and Accountability Policy 1.8.4 Appendix C Uses and Disclosures of PHI Procedures This Appendix covers procedures related to Uses and Disclosures of PHI. Disclosures to Law
The Society of Actuaries in Ireland Briefing Statement on Insurance provisions in the Disability Bill 2004 Introduction The Disability Bill published in September 2004 provides for certain restrictions
Presents WELLNESS PROGRAMS LEGAL CONSIDERATIONS SEPTEMBER 11, 2013 Felicia Finston, Wilkins Finston Law Group LLP Jackie Middleton, University of Colorado Hospital WHAT IS A WELLNESS PROGRAM? Any program
Psychology CLINICAL PRIVILEGE WHITE PAPER Psychology Background Psychology is a broad field that includes the scientific study of mental processes and behavior. It is similar to the medical field of psychiatry.
Model Code of Ethical Practice for Practitioners of Acupuncture and Oriental Medicine Preamble This document is not meant to supersede or conflict with any state or federal law. This document refers to
ATTACHMENT A TO FORMAL ATTORNEY GENERAL OPINION HIPAA PRIVACY MATRIX DISCLOSURES TO LAW ENFORCEMENT Reason for Disclosure HIPAA Cite Required or Permitted In Response or Voluntarily Required by law 164.512(a)
Virtual Mentor American Medical Association Journal of Ethics January 2012, Volume 14, Number 1: 31-34. HEALTH LAW The National Childhood Vaccine Injury Act and the Supreme Court s Interpretation Valarie
Connecticut Pipe Trades Health Fund Privacy Notice 2013 Restatement Section 1: Purpose of This Notice and Effective Date THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
Summary Plan Description BASIC LIFE INSURANCE 2015 Table of Contents Introduction... 1 Eligibility and Enrollment... 2 Eligibility... 2 Enrollment... 2 Designating a Beneficiary... 3 Employee Life Insurance...
Professional Pilot & Spouse Group Term Life Insurance No exclusions except suicide which is removed as an exclusion after two years of new coverage or increased coverage. Up to $150,000 in coverage available
A Manager s Guide to Reasonable Accommodation This guide is the responsibility of the Public Service Agency Province of British Columbia TABLE OF CONTENTS INTRODUCTION...2 KEY CONCEPTS...3 A. The Concept
For 2015 OPR bill October 17, 2014: TITLE TWENTY-SIX. PROFESSIONS AND OCCUPATIONS CHAPTER 61. CLINICAL SOCIAL WORKERS Sec. x 26 V.S.A. 3201 is amended to read: 26 V.S.A. 3201. Definitions As used in this
LIFESTREAM BEHAVIORAL CENTER, INC. JOINT NOTICE OF PRIVACY PRACTICES Effective Date: April 14, 2003 THIS DOCUMENT DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET
NOTICE OF HEALTH INFORMATION PRACTICES Effective Date: April 14, 2003 Date Amended: 9/5/13 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO
California State Firefighters Employee Welfare Benefits Corporation Simple, Affordable & SAFE! Limited Time Simplified Issue Offer Group Term Life Insurance Application (10-Year Level Term Rate) C2 ReliaStar
Protecting Your Health Insurance Coverage This booklet explains... Your rights and protections under recent Federal law How to help maintain existing coverage Where you can get more help For additional
9129 Monroe Rd. Suite 100, Charlotte, NC 28270 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE READ IT CAREFULLY.
Population Health Management Program Notice of Privacy Practices from Piedmont WellStar HealthPlans, Inc. Piedmont WellStar HealthPlans, Inc. (PWHP) provides population health management services to its
Claim Packet Instructions Your Disability Benefit Claim This packet contains the forms necessary to apply for disability benefits. It also addresses common questions about Disability claims. Please save
WELCOME TO STRAITH HOSPITAL FOR SPECIAL SURGERY During your stay with us, our goal is to make your hospital experience as favorable as possible by providing information and open channels of communication.
Privacy Notice Document (HIPAA) THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY. This Privacy
How Health Reform Will Help Children with Mental Health Needs The new health care reform law, called the Affordable Care Act (or ACA), will give children who have mental health needs better access to the
EMPLOYMENT In recent years, breakthroughs in treatment have allowed HIV-positive individuals to lead fulfilling lives with less severe symptoms. As a result, many people with HIV feel healthy enough to
Office for Human Research Protections (OHRP) Department of Health and Human Services (HHS) Guidance on the Genetic Information Nondiscrimination Act: Implications for Investigators and Institutional Review
Notice of Privacy Practices This notice describes how medical information about you may be used and disclosed and how you can get access to this information. Please review it carefully. Uses and Disclosures
How Health Coverage Works: Coverage Delivery, Risk Assessment, and Regulation The following summarizes the document How Private Health Coverage Works: A Primer 2008 Update published by the Kaiser Family
ACCIDENT INSURANCE CLAIM ReliaStar Life Insurance Company A member of the ING family of companies Administered by: Key Benefit Administrators, Inc., P.O. Box 1238 Fort Mill, SC 29716 Phone: 866-225-8704,
MIB Responds to Misleading Statements by AnnualMedicalReport.com June 30, 2014 The AnnualMedicalReport.com ( AMR ) website makes many misleading and inaccurate statements about MIB (formerly, the Medical
Indiana Healthcare Physician Services Privacy Standards Notice of Health Information Practices THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW TO GET ACCESS TO
c AK Steel Corporation Voluntary Term Life Insurance IAM Local 1943 Hourly Employees Summary Plan Description Effective March 15, 2007 Table of Contents Introduction... 1 Former Announcements... 1 Eligibility...
What Can We Learn About Federal ERISA Law from Maryland s Court Decision? Patricia A. Butler, JD, Dr.P.H. Family Impact Seminar January 24, 2007 Presentation Overview Background on ERISA preemption provisions
NOTICE OF PRIVACY PRACTICES ILLINOIS EYE CENTER THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED OR DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
National Conference of State Legislatures Discrimination Laws Regarding Off-Duty Conduct Updated October 18, 2010 The issue of employees' rights to engage in certain off-duty activities and in the competing
Associated Retina Consultant s, Ltd. Notice of Information Practices THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE
The Health and Benefit Trust Fund of the International Union of Operating Section 1: Purpose of This Notice Notice of Privacy Practices Effective as of September 23, 2013 THIS NOTICE DESCRIBES HOW MEDICAL
NOTICE OF PRIVACY PRACTICES Effective Date: April 14, 2003 UNIVERSITY OF CALIFORNIA DAVIS HEALTH SYSTEM THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN
EXCEL PHYSICAL THERAPY, INC. Medical History Form Name: Date of Birth: Date: Are you employed? YES NO Right Handed Left Handed If NO, last day worked? Do you smoke? YES NO #of packs/day Occupation: Height:
HIV/AIDS DISCRIMINATION Are You Breaking The Law? HALSA HIV & AIDS Legal Services Alliance Produced by the City of Los Angeles Department on Disability, AIDS Coordinator s Office HIV/AIDS DISCRIMINATION
NOTICE OF HEALTH INFORMATION PRIVACY PRACTICES (HIPAA) THIS NOTICE OF PRIVACY PRACTICES DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION.
DISCLOSURES OF PHI & FLORIDA STATE LAW The Privacy Rule provides an extensive list of permitted disclosures; however, if state laws provide greater privacy protections or privacy rights with respect to
Effective Date: 09/23/2013 Paul Beljan, PsyD, ABPdN, ABN Alison E.F. Reuter, PhD, ABPdN Laura Wingers, PsyD Kate Bree, PsyD Vanessa Berens, PhD Jacob Boney, PsyD, BCBA-D 9835 E. Bell Rd., Ste. 140 Scottsdale,
International Paralympic Committee Medical Code December 2011 This version of the IPC Medical Code has been approved by the IPC General Assembly December 2011. IPC Medical Code 1 Preamble 1. The Paralympic
SDC-League Health Fund 1501 Broadway, 17 th Floor New York, NY 10036 Tel: 212-869-8129 Fax: 212-302-6195 E-mail: firstname.lastname@example.org NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION
Population Health Management Program Notice of Privacy Practices Premier Health provides population health management services to its health plan members. Services include wellness program tools and technology,
Counseling Intake Form (Each person attending therapy should complete a form) Name Male Female Mailing Address Date of Birth Home Phone Work Email How would you like to be contacted? Home Work Email Okay
RETURN TO WORK POLICY APM 5.12 (Revised 5/2012) It is the policy of Sul Ross State University to provide a return to work program as the means to return employees to meaningful, productive employment following
Toll Free: 1-800-276-7619, Ext. 4264 AssureLINK Address: http://assurelink.assurity.com Tennessee Application for Acci-Flex Insurance This application includes all forms needed to apply for Acci-Flex Insurance.
Detailed Notice of Privacy Practices Effective Date: September 20, 2013 Purpose of This Notice: This Notice describes your legal rights, advises you of our privacy practices, and lets you know how Butler
Privacy Notice Please carefully review this notice. It describes how medical information about you may be used and disclosed and how you can get access to this information. The Health Insurance Portability
Legal Issues for People with HIV Duke Legal Project Box 90360 Durham, NC 27708-0360 (919) 613-7169 (888) 600-7274 Duke Legal Project is a clinical legal education program of Duke Law School. Legal Representation
Rev.10-2013-KB P-drive-HR Forms NOTICE OF HEALTH INFORMATION PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED OR DISCLOSED BY United Cerebral Palsy of Miami (UCP) and